Dinotefuran; Pesticide Tolerances, 56133-56138 [2012-22205]
Download as PDF
Federal Register / Vol. 77, No. 177 / Wednesday, September 12, 2012 / Rules and Regulations
Authority: 21 U.S.C. 321(q), 346a and 371.
FOR FURTHER INFORMATION CONTACT:
§ 180.1285 Polyoxin D zinc salt; exemption
from the requirement of a tolerance.
An exemption from the requirement
of a tolerance is established for the
residues of polyoxin D zinc salt in or on
all food commodities when applied as a
fungicide and used in accordance with
good agricultural practices.
Andrew Ertman, Registration Division,
Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number:
(703) 308–9367; email address:
ertman.andrew@epa.gov.
SUPPLEMENTARY INFORMATION:
2. Section 180.1285 is revised to read
as follows:
■
[FR Doc. 2012–22315 Filed 9–11–12; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2011–0433; FRL–9359–6]
Dinotefuran; Pesticide Tolerances
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes
tolerances for residues of dinotefuran in
or on multiple commodities which are
identified and discussed later in this
document. Also, due to the tolerances
established by this document, the
Agency is removing the existing
tolerances for grape and potato as
unnecessary. Interregional Research
Project Number 4 (IR–4) requested these
tolerances under the Federal Food,
Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective
September 12, 2012. Objections and
requests for hearings must be received
on or before November 13, 2012, and
must be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2011–0433, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), EPA West
Bldg., Rm. 3334, 1301 Constitution Ave.
NW., Washington, DC 20460–0001. The
Public Reading Room is open from 8:30
a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The
telephone number for the Public
Reading Room is (202) 566–1744, and
the telephone number for the OPP
Docket is (703) 305–5805. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
srobinson on DSK4SPTVN1PROD with RULES
SUMMARY:
VerDate Mar<15>2010
17:19 Sep 11, 2012
Jkt 226001
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s e-CFR
site at https://ecfr.gpoaccess.gov/cgi/t/
text/text-idx?&c=ecfr&tpl=/ecfrbrowse/
Title40/40tab_02.tpl.
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2011–0433 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing, and must be
received by the Hearing Clerk on or
before November 13, 2012. Addresses
for mail and hand delivery of objections
and hearing requests are provided in 40
CFR 178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
PO 00000
Frm 00041
Fmt 4700
Sfmt 4700
56133
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2011–0433, by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be CBI or
other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW., Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.htm.
Additional instructions on commenting
or visiting the docket, along with more
information about dockets generally, is
available at https://www.epa.gov/
dockets.
II. Summary of Petitioned-For
Tolerance
In the Federal Register of September
7, 2011 (76 FR 55329) (FRL–8886–7),
EPA issued a notice pursuant to FFDCA
section 408(d)(3), 21 U.S.C. 346a(d)(3),
announcing the filing of a pesticide
petition (PP 1E7863) by IR–4, 500
College Rd. East, Suite 201 W,
Princeton, NJ 08540. The petition
requested that 40 CFR 180.603 be
amended by establishing tolerances for
residues of the insecticide dinotefuran,
(RS)-1-methyl-2-nitro-3-((tetrahydro-3furyl)methyl)guanidine, including its
metabolites and degradates, in or on
berry, low growing, except strawberry,
subgroup 13–07H at 0.2 parts per
million (ppm); watercress at 5.0 ppm;
onion, green, subgroup 3–07B at 6.0
ppm; onion, bulb, subgroup 3–07A at
0.07 ppm; peach at 0.9 ppm; vegetable,
tuberous and corm, subgroup 1C at 0.05
ppm; fruit, small, vine climbing, except
fuzzy kiwifruit, subgroup 13–07F at 0.9
ppm; and tea, plucked leaves at 25.0
ppm. That notice referenced a summary
of the petition prepared by Mitsui
Chemicals Agro, Inc., the registrant,
which is available in the docket, https://
www.regulations.gov. There were no
comments received in response to the
notice of filing.
Also, due to the tolerances established
by this document, the following existing
tolerances are being removed as
unnecessary: Grape and potato.
Based upon review of the data
supporting the petition, EPA has
E:\FR\FM\12SER1.SGM
12SER1
56134
Federal Register / Vol. 77, No. 177 / Wednesday, September 12, 2012 / Rules and Regulations
modified the levels for which tolerances
are being established for the bulb onion
subgroup 3–07A, the green onion
subgroup 3–07B, peach, tea, and
watercress. The reason for these changes
is explained in Unit IV.C.
srobinson on DSK4SPTVN1PROD with RULES
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. * * *’’
Consistent with FFDCA section
408(b)(2)(D), and the factors specified in
FFDCA section 408(b)(2)(D), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for dinotefuran
including exposure resulting from the
tolerances established by this action.
EPA’s assessment of exposures and risks
associated with dinotefuran follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children. Dinotefuran has
low acute toxicity by oral, dermal, and
inhalation exposure routes. It is not a
dermal sensitizer, but causes a low level
of skin irritation. The main target of
toxicity is the nervous system but effects
on the nervous system were only
observed at high doses. Nervous system
toxicity was manifested as clinical signs
and decreased motor activity seen after
acute dosing (in both rats and rabbits)
VerDate Mar<15>2010
17:19 Sep 11, 2012
Jkt 226001
and changes in motor activity which are
consistent with effects on the nicotinic
cholinergic nervous system seen after
repeated dosing. Typically, low to
moderate levels of neonicotinoids, such
as dinotefuran, activate the nicotinic
acetylcholine receptors causing
stimulation of the peripheral nervous
system (PNS). High levels of
neonicotinoids can over stimulate the
PNS, maintaining cation channels in the
open state which blocks the action
potential and leads to paralysis.
Dinotefuran was well tolerated at high
doses following dietary administration
for ninety days to mice, rats, and dogs.
The most sensitive effects were
decreases in body weight and/or body
weight gain but even these effects
occurred at or near the limit dose.
Changes in spleen and thymus weights
were seen in mice, rats and dogs
following subchronic and chronic
dietary exposures. However, these
weight changes were not corroborated
with alterations in hematology
parameters, histopathological lesions in
these organs, or toxicity to the
hematopoietic system. Furthermore, the
toxicology data base contains
immunotoxicity studies in mice and rats
and a developmental immunotoxicity
study in rats. In the immunotoxicity
studies there were no effect on T-cell
dependent antibody response (TDAR)
when tested up to the limit dose in male
and female mice and in male and female
rats. There were no changes in spleen
and thymus weight and there were no
histopathological lesions in these organs
in those studies. In the developmental
immunotoxicity study, there was no
evidence of an effect on the
functionality of the immune system in
rats that were exposed to dinotefuran at
the limit dose during the prenatal,
postnatal, and post-weaning periods.
Consequently, the thymus weight
changes seen in dogs and the spleen
weight changes seen in mice and rats
were not considered to be
toxicologically relevant.
No systemic or neurotoxicity was seen
following repeated dermal applications
at the limit dose to rats for 28 days. No
systemic or portal of entry effects were
seen following repeated inhalation
exposure at the maximum obtainable
concentrations to rats for 28 days.
In the pre-natal studies, no maternal
or developmental toxicity was seen at
the limit dose in rats. In rabbits,
maternal toxicity manifested as clinical
signs of neurotoxicity but no
developmental toxicity was seen. In the
reproduction study, parental, offspring,
and reproductive toxicity was seen at
the limit dose. Parental toxicity
included decreased body weight gain,
PO 00000
Frm 00042
Fmt 4700
Sfmt 4700
transient decrease in food consumption,
and decreased thyroid weights.
Offspring toxicity was characterized as
decreased forelimb grip strength or
hindlimb grip strength in the F1 pups.
There was no adverse effect on
reproductive performance at any dose.
In the developmental neurotoxicity
study, no maternal or offspring toxicity
was seen at any dose including the limit
dose.
There was no evidence of
carcinogenicity in male and female mice
and in male and female rats fed diets
containing dinotefuran at the limit dose
for 78 weeks to mice and 104 weeks to
rats. Dinotefuran was non-mutagenic in
both in vivo and in vitro assays.
Specific information on the studies
received and the nature of the adverse
effects caused by dinotefuran as well as
the no-observed-adverse-effect-level
(NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the
toxicity studies can be found at https://
www.regulations.gov on pages 39–44 of
the document titled ‘‘Revised:
Dinotefuran: Human Health Risk
Assessment for Proposed Section 3 Uses
on Tuberous and Corm Vegetables
Subgroup 1C, Onion Subgroup 3–07A,
Onion Subgroup 3–07B, Small Fruit
Subgroup 13–07F, Berry Subgroup 13–
07H, Peach, and Watercress, And a
Tolerance on Imported Tea’’ in docket
ID number EPA–HQ–OPP–2011–0433.
B. Toxicological Points of Departure/
Levels of Concern
Once a pesticide’s toxicological
profile is determined, EPA identifies
toxicological points of departure (POD)
and levels of concern to use in
evaluating the risk posed by human
exposure to the pesticide. For hazards
that have a threshold below which there
is no appreciable risk, the toxicological
POD is used as the basis for derivation
of reference values for risk assessment.
PODs are developed based on a careful
analysis of the doses in each
toxicological study to determine the
dose at which no adverse effects are
observed (the NOAEL) and the lowest
dose at which adverse effects of concern
are identified (the LOAEL). Uncertainty/
safety factors are used in conjunction
with the POD to calculate a safe
exposure level—generally referred to as
a population-adjusted dose (PAD) or a
reference dose (RfD)—and a safe margin
of exposure (MOE). For non-threshold
risks, the Agency assumes that any
amount of exposure will lead to some
degree of risk. Thus, the Agency
estimates risk in terms of the probability
of an occurrence of the adverse effect
expected in a lifetime. For more
information on the general principles
E:\FR\FM\12SER1.SGM
12SER1
Federal Register / Vol. 77, No. 177 / Wednesday, September 12, 2012 / Rules and Regulations
EPA uses in risk characterization and a
complete description of the risk
assessment process, see https://
www.epa.gov/pesticides/factsheets/
riskassess.htm.
A summary of the toxicological
endpoints for dinotefuran used for
human risk assessment is shown in the
Table of this unit. EPA notes that in the
last final rule for dinotefuran, published
in the Federal Register of December 18,
2009 (74 FR 67098) (FRL–8803–1), the
points of departure for many exposure
scenarios differ than what is reported in
this document. Since the last risk
assessment, the Agency has re-evaluated
the dinotefuran toxicological database
and updated the hazard characterization
and dose response assessment. This
toxicology database reevaluation has
resulted in changes to the toxicity
endpoints, points of departure, and
safety factors for several routes of
exposure from those presented in
previous EPA risk assessments for
dinotefuran. For a more detailed
56135
discussion of the endpoint selection and
reasons for the changes, refer to
Appendix A.3 on pages 44–47 in the
document titled ‘‘Dinotefuran: Human
Health Risk Assessment for Proposed
Section 3 Uses on Tuberous and Corm
Vegetables Subgroup 1C, Onion
Subgroup 3–07A, Onion Subgroup 3–
07B, Small Fruit Subgroup 13–07F,
Berry Subgroup 13–07H, Peach, and
Watercress, And a Tolerance on
Imported Tea’’ in docket ID number
EPA–HQ–OPP–2011–0433.
TABLE—SUMMARY OF TOXICOLOGICAL DOSES AND ENDPOINTS FOR DINOTEFURAN FOR USE IN HUMAN HEALTH RISK
ASSESSMENT
Exposure/scenario
Acute dietary (General population including infants and
children).
Chronic dietary (All populations)
Incidental Oral Short-Term (1–
30 days).
Point of departure
and
uncertainty/safety
factors
NOAEL = 125 mg/
kg/day.
UFA = 10X
UFH = 10X
FQPA SF = 1X
NOAEL= 99.7 mg/
kg/day.
UFA = 10X
UFH = 10X
FQPA SF = 1X
NOAEL= 99.7 mg/
kg/day.
UFA = 10X
UFH = 10X
FQPA SF = 1X
RfD, PAD, LOC for
risk assessment
Study and toxicological effects
Acute RfD = 1.25
mg/kg/day.
aPAD = 1.25 mg/kg/
day
Developmental Toxicity Study in Rabbits
LOAEL = 300 mg/kg/day based on clinical signs in does (prone
position, panting, tremor and erythema) seen following the
first dose on Gestation Day 6.
Chronic RfD = 1.0
mg/kg/day.
cPAD = 1.0 mg/kg/
day
Chronic Toxicity/Carcinogenicity Study in Rats LOAEL = 991
mg/kg/day based on decreased body weight gain and
nephrotoxicity.
LOC for MOE = 100
Chronic Toxicity/Carcinogenicity Study in Rats LOAEL = 991
mg/kg/day based on decreased body weight gain and
nephrotoxicity.
FQPA SF = Food Quality Protection Act Safety Factor. LOAEL = lowest-observed-adverse-effect-level. LOC = level of concern. mg/kg/day =
milligram/kilogram/day. MOE = margin of exposure. NOAEL = no-observed-adverse-effect-level. PAD = population adjusted dose (a = acute, c =
chronic). RfD = reference dose. UF = uncertainty factor. UFA = extrapolation from animal to human (interspecies). UFH = potential variation in
sensitivity among members of the human population (intraspecies).
srobinson on DSK4SPTVN1PROD with RULES
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to dinotefuran, EPA
considered exposure under the
petitioned-for tolerances as well as all
existing dinotefuran tolerances in 40
CFR 180.603. EPA assessed dietary
exposures from dinotefuran in food as
follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1-day or single
exposure.
Such effects were identified for
dinotefuran. In estimating acute dietary
exposure, EPA used food consumption
information from the United States
Department of Agriculture (USDA)
1994–1996 and 1998 Nationwide
Continuing Surveys of Food Intake by
Individuals (CSFII). As to residue levels
in food, EPA assumed 100 percent crop
treated (PCT) and tolerance-level
VerDate Mar<15>2010
17:19 Sep 11, 2012
Jkt 226001
residues for all current and proposed
crops.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used the food consumption data
from the USDA 1994–1996 and 1998
CSFII. As to residue levels in food, EPA
assumed 100 PCT and tolerance-level
residues for all current and proposed
crops.
iii. Cancer. Based on the data
summarized in Unit III.A., EPA has
concluded that dinotefuran does not
pose a cancer risk to humans. Therefore,
a dietary exposure assessment for the
purpose of assessing cancer risk is
unnecessary.
iv. Anticipated residue and PCT
information. EPA did not use
anticipated residue or PCT information
in the dietary assessment for
dinotefuran. Tolerance level residues
and 100 PCT were assumed for all food
commodities.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
PO 00000
Frm 00043
Fmt 4700
Sfmt 4700
for dinotefuran in drinking water. These
simulation models take into account
data on the physical, chemical, and fate/
transport characteristics of dinotefuran.
Further information regarding EPA
drinking water models used in pesticide
exposure assessment can be found at
https://www.epa.gov/oppefed1/models/
water/index.htm.
Based on the First Index Reservoir
Screening Tool (FIRST), and Screening
Concentration in Ground Water (SCI–
GROW) models, the estimated drinking
water concentrations (EDWCs) of
dinotefuran for acute exposures are
estimated to be 91.31 parts per billion
(ppb) for surface water and 3.5 ppb for
ground water and for chronic exposures
for non-cancer assessments are
estimated to be 25.16 ppb for surface
water and 3.5 ppb for ground water.
Modeled estimates of drinking water
concentrations were directly entered
into the dietary exposure model. For
acute dietary risk assessment, the water
concentration value of 91.31 ppb was
used to assess the contribution to
drinking water. For chronic dietary risk
E:\FR\FM\12SER1.SGM
12SER1
srobinson on DSK4SPTVN1PROD with RULES
56136
Federal Register / Vol. 77, No. 177 / Wednesday, September 12, 2012 / Rules and Regulations
assessment, the water concentration of
value 25.16 ppb was used to assess the
contribution to drinking water.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets).
Dinotefuran is currently registered for
the following uses that could result in
residential exposures: Turf,
ornamentals, vegetable gardens, pets,
indoor aerosol sprays, and crack and
crevice sprays. EPA assessed residential
exposure using the following
assumptions: Residential handler
exposures were not assessed because no
dermal or inhalation hazards were
identified. For this same reason, postapplication residential dermal and
inhalation exposure scenarios were not
assessed. The Agency only considered
post-application scenarios in which
incidental oral exposures to children are
expected. The oral exposures assessed
included incidental oral exposures from
turf, ant bait, ready to use garden trigger
sprayers, dog and cat spot on treatment,
indoor broadcast, and indoor crack and
crevice uses. Of all these scenarios,
treated turf was determined to result in
the highest levels of exposure.
In assessing risks from residential
exposures, EPA combines different
residential sources of exposure that
could reasonably be expected to occur
on the same day. While it is possible for
children to be exposed to indoor
broadcast sprays on hard surfaces/
carpets and to spot-on treatment to cats
or dogs on the same day, these
exposures have not been combined in
this assessment because incidental oral
hand-to-mouth exposure from treated
turf is higher and still results in an MOE
that does not exceed the Agency’s LOC.
Further information regarding EPA
standard assumptions and generic
inputs for residential exposures may be
found at https://www.epa.gov/pesticides/
trac/science/trac6a05.pdf.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found dinotefuran to
share a common mechanism of toxicity
with any other substances, and
dinotefuran does not appear to produce
a toxic metabolite produced by other
VerDate Mar<15>2010
17:19 Sep 11, 2012
Jkt 226001
substances. For the purposes of this
tolerance action, therefore, EPA has
assumed that dinotefuran does not have
a common mechanism of toxicity with
other substances. For information
regarding EPA’s efforts to determine
which chemicals have a common
mechanism of toxicity and to evaluate
the cumulative effects of such
chemicals, see EPA’s Web site at https://
www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(C) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA Safety Factor (SF). In applying
this provision, EPA either retains the
default value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
In the pre-natal studies, no maternal or
developmental toxicity was seen at the
limit dose in rats. In rabbits, maternal
toxicity manifested as clinical signs of
neurotoxicity but no developmental
toxicity was seen. In the reproduction
study, parental, offspring, and
reproductive toxicity was seen at the
limit dose. Parental toxicity included
decreased body weight gain, transient
decrease in food consumption, and
decreased thyroid weights. Offspring
toxicity was characterized as decreased
forelimb grip strength or hindlimb grip
strength in the F1 pups. There was no
adverse effect on reproductive
performance at any dose. In the
developmental neurotoxicity study, no
maternal or offspring toxicity was seen
at any dose including the limit dose.
3. Conclusion. EPA has determined
that reliable data show the safety of
infants and children would be
adequately protected if the FQPA SF
were reduced to 1X. That decision is
based on the following findings:
i. The toxicity database for
dinotefuran is complete.
ii. The neurotoxic potential of
dinotefuran has been adequately
considered. Dinotefuran is a
neonicotinoid and has a neurotoxic
mode of pesticidal action. Consistent
with the mode of action, changes in
motor activity were seen in repeat-dose
studies, including the subchronic
PO 00000
Frm 00044
Fmt 4700
Sfmt 4700
neurotoxicity study. Additionally,
decreased grip strength and brain
weight was observed in the offspring of
a multi-generation reproduction study
albeit at doses close to the limit dose.
For these reasons, a developmental
neurotoxicity study was required. Upon
review of the developmental
neurotoxicity study, it was concluded
that there is no evidence of a unique
sensitivity to the developing nervous
system since no effects on
neurobehavioral parameters were seen
in the offspring at doses that
approached or exceeded the limit dose.
iii. There is no evidence that
dinotefuran results in increased
susceptibility in in utero rats or rabbits
in the prenatal developmental studies or
in young rats in the 2-generation
reproduction study.
iv. There are no residual uncertainties
identified in the exposure databases.
The dietary food exposure assessments
were performed based on 100 PCT and
tolerance-level residues. EPA made
conservative (protective) assumptions in
the ground and surface water modeling
used to assess exposure to dinotefuran
in drinking water. EPA used similarly
conservative assumptions to assess
postapplication exposure of children for
incidental oral exposures. These
assessments will not underestimate the
exposure and risks posed by
dinotefuran.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic dietary pesticide exposures are
safe by comparing aggregate exposure
estimates to the acute PAD (aPAD) and
chronic PAD (cPAD). For linear cancer
risks, EPA calculates the lifetime
probability of acquiring cancer given the
estimated aggregate exposure. Short-,
intermediate-, and chronic-term risks
are evaluated by comparing the
estimated aggregate food, water, and
residential exposure to the appropriate
PODs to ensure that an adequate MOE
exists.
1. Acute risk. Using the exposure
assumptions discussed in this unit for
acute exposure, the acute dietary
exposure from food and water to
dinotefuran will occupy 5.8% of the
aPAD for children 1–2 years old, the
population group receiving the greatest
exposure.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to dinotefuran
from food and water will utilize 2.6% of
the cPAD for children 1–2 years old, the
population group receiving the greatest
exposure. Based on the explanation in
E:\FR\FM\12SER1.SGM
12SER1
srobinson on DSK4SPTVN1PROD with RULES
Federal Register / Vol. 77, No. 177 / Wednesday, September 12, 2012 / Rules and Regulations
Unit III.C.3., regarding residential use
patterns, chronic residential exposure to
residues of dinotefuran is not expected.
3. Short-term risk. Short-term
aggregate exposure takes into account
short-term residential exposure plus
chronic exposure to food and water
(considered to be a background
exposure level).
Dinotefuran is currently registered for
uses that could result in short-term
residential exposure, and the Agency
has determined that it is appropriate to
aggregate chronic exposure through food
and water with short-term residential
exposures to dinotefuran.
Using the exposure assumptions
described in this unit for short-term
exposures, EPA has concluded the
combined short-term food, water, and
residential exposures result in an
aggregate MOE of 3,000 for children 1–
2 years old from hand to mouth
exposure from treated turf, the scenario
with the highest exposure. Because
EPA’s level of concern for dinotefuran is
a MOE of 100 or below, this MOE is not
of concern.
4. Intermediate-term risk.
Intermediate-term aggregate exposure
takes into account intermediate-term
residential exposure plus chronic
exposure to food and water (considered
to be a background exposure level).
Intermediate-term exposure is not
expected for the adult residential
exposure pathway. Therefore, the
intermediate-term aggregate risk would
be equivalent to the chronic dietary
exposure estimate. For children,
intermediate-term incidental oral
exposures could potentially occur from
indoor uses. However, while it is
possible for children to be exposed for
longer durations, the magnitude of
residues is expected to be lower due to
dissipation or other activities. Since
incidental oral short- and intermediateterm toxicity endpoints and points of
departure are the same, the short-term
aggregate risk estimate, which includes
the highest residential exposure
estimate (from turf), is protective of any
intermediate-term exposures.
5. Aggregate cancer risk for U.S.
population. Based on the lack of
evidence of carcinogenicity in two
adequate rodent carcinogenicity studies,
dinotefuran is not expected to pose a
cancer risk to humans.
6. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population or to infants and children
from aggregate exposure to dinotefuran
residues.
VerDate Mar<15>2010
17:19 Sep 11, 2012
Jkt 226001
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology
(a high performance liquid
chromatography/tandem mass
spectrometry (HPLC/MS/MS) method
for the determination of residues of
dinotefuran, and the metabolites DN,
and UF; an HPLC/ultraviolet (UV)
detection method for the determination
of residues of dinotefuran; and HPLC/
MS and HPLC/MS/MS methods for the
determination of DN and UF) is
available to enforce the tolerance
expression.
The method may be requested from:
Chief, Analytical Chemistry Branch,
Environmental Science Center, 701
Mapes Rd., Ft. Meade, MD 20755–5350;
telephone number: (410) 305–2905;
email address:
residuemethods@epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint
United Nations Food and Agriculture
Organization/World Health
Organization food standards program,
and it is recognized as an international
food safety standards-setting
organization in trade agreements to
which the United States is a party. EPA
may establish a tolerance that is
different from a Codex MRL; however,
FFDCA section 408(b)(4) requires that
EPA explain the reasons for departing
from the Codex level.
The Codex has not established a MRL
for dinotefuran for any of the
commodities in this Notice.
C. Revisions to Petitioned-For
Tolerances
Use of the Organization of Economic
and Cooperation and Development
tolerance calculation procedures
indicates that the tolerances for residues
in/on the onion subgroup 3–07A, onion
subgroup 3–07B, peach, tea, and
watercress should be established at 0.15
ppm, 5.0 ppm, 1.0 ppm, 50 ppm, and
8.0 ppm, respectively, instead of those
values proposed.
V. Conclusion
Therefore, tolerances are established
for residues of dinotefuran, (RS)-1methyl-2-nitro-3-((tetrahydro-3-
PO 00000
Frm 00045
Fmt 4700
Sfmt 4700
56137
furyl)methyl)guanidine, including its
metabolites and degradates, in or on
berry, low growing, except strawberry,
subgroup 13–07H at 0.2 ppm; watercress
at 8.0 ppm; onion, green, subgroup 3–
07B at 5.0 ppm; onion, bulb, subgroup
3–07A at 0.15 ppm; peach at 1.0 ppm;
vegetable, tuberous and corm, subgroup
1C at 0.05 ppm; fruit, small, vine
climbing, except fuzzy kiwifruit,
subgroup 13–07F at 0.9 ppm; and tea,
dried at 50 ppm.
Also, the following existing tolerances
are removed as unnecessary: Grape and
potato. These commodities are covered
by the new crop group tolerances for
fruit, small, vine climbing, except fuzzy
kiwifruit, subgroup 13–07F, and
vegetable, tuberous and corm, subgroup
1C.
VI. Statutory and Executive Order
Reviews
This final rule establishes tolerances
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this final rule
has been exempted from review under
Executive Order 12866, this final rule is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001) or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997). This final rule does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), nor does it require
any special considerations under
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This final rule directly regulates
growers, food processors, food handlers,
and food retailers, not States or tribes,
nor does this action alter the
relationships or distribution of power
and responsibilities established by
Congress in the preemption provisions
E:\FR\FM\12SER1.SGM
12SER1
56138
Federal Register / Vol. 77, No. 177 / Wednesday, September 12, 2012 / Rules and Regulations
of FFDCA section 408(n)(4). As such,
the Agency has determined that this
action will not have a substantial direct
effect on States or tribal governments,
on the relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
‘‘Federalism’’ (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled ‘‘Consultation and Coordination
with Indian Tribal Governments’’ (65 FR
67249, November 9, 2000) do not apply
to this final rule. In addition, this final
rule does not impose any enforceable
duty or contain any unfunded mandate
as described under Title II of the
Unfunded Mandates Reform Act of 1995
(UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act of 1995
(NTTAA) (15 U.S.C. 272 note).
§ 180.603 Dinotefuran; tolerances for
residues.
VII. Congressional Review Act
*
Vegetable, tuberous and
corm, subgroup 1C .............
Watercress ..............................
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: August 28, 2012.
Lois Rossi,
Director, Registration Division, Office of
Pesticide Programs.
*
*
*
*
Fruit, small vine climbing, except fuzzy kiwifruit, subgroup 13–07F ......................
*
*
*
*
Onion, bulb, subgroup 3–07A
Onion, green, subgroup 3–
07B ......................................
Peach ......................................
*
*
*
*
Tea, dried1 ..............................
*
*
*
1 There
*
Authority: 21 U.S.C. 321(q), 346a and 371.
2. Section § 180.603 is amended by
removing the entries for ‘‘Grape’’ and
‘‘Potato’’ and alphabetically adding the
following entries and a footnote to the
table in paragraph (a)(1) to read as
follows:
■
Jkt 226001
0.05
8.0
are no U.S. registrations for tea.
*
*
*
*
[FR Doc. 2012–22205 Filed 9–11–12; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. CDC–2012–0007; NIOSH–257]
42 CFR Part 88
RIN 0920–AA49
World Trade Center Health Program;
Addition of Certain Types of Cancer to
the List of WTC-Related Health
Conditions
Title I of the James Zadroga 9/
11 Health and Compensation Act of
2010 amended the Public Health Service
Act (PHS Act) to establish the World
Trade Center (WTC) Health Program.
The WTC Health Program, which is
administered by the Director of the
National Institute for Occupational
Safety and Health (NIOSH), within the
Centers for Disease Control and
Prevention (CDC), provides medical
SUMMARY:
1. The authority citation for part 180
continues to read as follows:
■
srobinson on DSK4SPTVN1PROD with RULES
Berry, low growing, except
strawberry, subgroup 13–
07H ......................................
Centers for Disease Control and
Prevention, HHS.
ACTION: Final rule.
PART 180—[AMENDED]
17:19 Sep 11, 2012
Commodity
AGENCY:
Therefore, 40 CFR chapter I is
amended as follows:
VerDate Mar<15>2010
(a) * * *
(1) * * *
monitoring and treatment to eligible
firefighters and related personnel, law
enforcement officers, and rescue,
recovery, and cleanup workers who
responded to the September 11, 2001,
Parts per
terrorist attacks in New York City, at the
million
Pentagon, and in Shanksville,
Pennsylvania, and to eligible survivors
of the New York City attacks. In
accordance with WTC Health Program
0.2
regulations, which establish procedures
*
for adding a new condition to the list of
*
covered health conditions, this final
*
rule adds to the List of WTC-Related
Health Conditions the types of cancer
proposed for inclusion by the notice of
0.9
proposed rulemaking.
DATES: This final rule is effective
*
*
October 12, 2012.
*
FOR FURTHER INFORMATION CONTACT:
0.15 Frank J. Hearl, PE, Chief of Staff,
National Institute for Occupational
5.0
Safety and Health, Centers for Disease
1.0
Control and Prevention, Patriots Plaza,
Suite 9200, 395 E St. SW., Washington,
*
DC 20201. Telephone: (202) 245–0625
*
*
(this is not a toll-free number). Email:
50
WTCpublicinput@cdc.gov.
SUPPLEMENTARY INFORMATION: This
*
notice of final rulemaking is organized
*
as follows:
*
PO 00000
Frm 00046
Fmt 4700
Sfmt 4700
I. Executive Summary
II. Public Participation
III. Background
A. WTC Health Program Statutory
Authority
B. Need for Rulemaking
C. Review of Scientific Evidence
D. Physician Determination and Program
Certification of WTC-Related Health
Conditions Including Types of Cancer
E. Effects of Rulemaking on Federal
Agencies
IV. Methods Used by the Administrator To
Determine Whether To Add Cancer or
Types of Cancer to the List of WTCRelated Health Conditions
V. Administrator’s Determination Concerning
Petition 001: Addition of Cancers to the
List of WTC-Related Health Conditions,
42 CFR 88.1
VI. Summary of Final Rule and Response to
Public Comments
VII. Regulatory Assessment Requirements
A. Executive Order 12866 and Executive
Order 13563
B. Regulatory Flexibility Act
C. Paperwork Reduction Act
D. Small Business Regulatory Enforcement
Fairness Act
E. Unfunded Mandates Reform Act of 1995
F. Executive Order 12988 (Civil Justice)
G. Executive Order 13132 (Federalism)
H. Executive Order 13045 (Protection of
Children From Environmental Health
Risks and Safety Risks)
I. Executive Order 13211 (Actions
Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use)
J. Plain Writing Act of 2010
VIII. Final Rule
E:\FR\FM\12SER1.SGM
12SER1
Agencies
[Federal Register Volume 77, Number 177 (Wednesday, September 12, 2012)]
[Rules and Regulations]
[Pages 56133-56138]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22205]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2011-0433; FRL-9359-6]
Dinotefuran; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
dinotefuran in or on multiple commodities which are identified and
discussed later in this document. Also, due to the tolerances
established by this document, the Agency is removing the existing
tolerances for grape and potato as unnecessary. Interregional Research
Project Number 4 (IR-4) requested these tolerances under the Federal
Food, Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective September 12, 2012. Objections and
requests for hearings must be received on or before November 13, 2012,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2011-0433, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), EPA West Bldg., Rm. 3334, 1301 Constitution
Ave. NW., Washington, DC 20460-0001. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202)
566-1744, and the telephone number for the OPP Docket is (703) 305-
5805. Please review the visitor instructions and additional information
about the docket available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Andrew Ertman, Registration Division,
Office of Pesticide Programs, Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:
(703) 308-9367; email address: ertman.andrew@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Printing Office's e-CFR site at https://ecfr.gpoaccess.gov/cgi/t/text/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2011-0433 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing, and must be received by the Hearing Clerk on or before
November 13, 2012. Addresses for mail and hand delivery of objections
and hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2011-0433, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.htm.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Summary of Petitioned-For Tolerance
In the Federal Register of September 7, 2011 (76 FR 55329) (FRL-
8886-7), EPA issued a notice pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
1E7863) by IR-4, 500 College Rd. East, Suite 201 W, Princeton, NJ
08540. The petition requested that 40 CFR 180.603 be amended by
establishing tolerances for residues of the insecticide dinotefuran,
(RS)-1-methyl-2-nitro-3-((tetrahydro-3-furyl)methyl)guanidine,
including its metabolites and degradates, in or on berry, low growing,
except strawberry, subgroup 13-07H at 0.2 parts per million (ppm);
watercress at 5.0 ppm; onion, green, subgroup 3-07B at 6.0 ppm; onion,
bulb, subgroup 3-07A at 0.07 ppm; peach at 0.9 ppm; vegetable, tuberous
and corm, subgroup 1C at 0.05 ppm; fruit, small, vine climbing, except
fuzzy kiwifruit, subgroup 13-07F at 0.9 ppm; and tea, plucked leaves at
25.0 ppm. That notice referenced a summary of the petition prepared by
Mitsui Chemicals Agro, Inc., the registrant, which is available in the
docket, https://www.regulations.gov. There were no comments received in
response to the notice of filing.
Also, due to the tolerances established by this document, the
following existing tolerances are being removed as unnecessary: Grape
and potato.
Based upon review of the data supporting the petition, EPA has
[[Page 56134]]
modified the levels for which tolerances are being established for the
bulb onion subgroup 3-07A, the green onion subgroup 3-07B, peach, tea,
and watercress. The reason for these changes is explained in Unit IV.C.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. * *
*''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for dinotefuran including exposure
resulting from the tolerances established by this action. EPA's
assessment of exposures and risks associated with dinotefuran follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children. Dinotefuran has low acute toxicity by oral, dermal, and
inhalation exposure routes. It is not a dermal sensitizer, but causes a
low level of skin irritation. The main target of toxicity is the
nervous system but effects on the nervous system were only observed at
high doses. Nervous system toxicity was manifested as clinical signs
and decreased motor activity seen after acute dosing (in both rats and
rabbits) and changes in motor activity which are consistent with
effects on the nicotinic cholinergic nervous system seen after repeated
dosing. Typically, low to moderate levels of neonicotinoids, such as
dinotefuran, activate the nicotinic acetylcholine receptors causing
stimulation of the peripheral nervous system (PNS). High levels of
neonicotinoids can over stimulate the PNS, maintaining cation channels
in the open state which blocks the action potential and leads to
paralysis.
Dinotefuran was well tolerated at high doses following dietary
administration for ninety days to mice, rats, and dogs. The most
sensitive effects were decreases in body weight and/or body weight gain
but even these effects occurred at or near the limit dose. Changes in
spleen and thymus weights were seen in mice, rats and dogs following
subchronic and chronic dietary exposures. However, these weight changes
were not corroborated with alterations in hematology parameters,
histopathological lesions in these organs, or toxicity to the
hematopoietic system. Furthermore, the toxicology data base contains
immunotoxicity studies in mice and rats and a developmental
immunotoxicity study in rats. In the immunotoxicity studies there were
no effect on T-cell dependent antibody response (TDAR) when tested up
to the limit dose in male and female mice and in male and female rats.
There were no changes in spleen and thymus weight and there were no
histopathological lesions in these organs in those studies. In the
developmental immunotoxicity study, there was no evidence of an effect
on the functionality of the immune system in rats that were exposed to
dinotefuran at the limit dose during the prenatal, postnatal, and post-
weaning periods. Consequently, the thymus weight changes seen in dogs
and the spleen weight changes seen in mice and rats were not considered
to be toxicologically relevant.
No systemic or neurotoxicity was seen following repeated dermal
applications at the limit dose to rats for 28 days. No systemic or
portal of entry effects were seen following repeated inhalation
exposure at the maximum obtainable concentrations to rats for 28 days.
In the pre-natal studies, no maternal or developmental toxicity was
seen at the limit dose in rats. In rabbits, maternal toxicity
manifested as clinical signs of neurotoxicity but no developmental
toxicity was seen. In the reproduction study, parental, offspring, and
reproductive toxicity was seen at the limit dose. Parental toxicity
included decreased body weight gain, transient decrease in food
consumption, and decreased thyroid weights. Offspring toxicity was
characterized as decreased forelimb grip strength or hindlimb grip
strength in the F1 pups. There was no adverse effect on reproductive
performance at any dose. In the developmental neurotoxicity study, no
maternal or offspring toxicity was seen at any dose including the limit
dose.
There was no evidence of carcinogenicity in male and female mice
and in male and female rats fed diets containing dinotefuran at the
limit dose for 78 weeks to mice and 104 weeks to rats. Dinotefuran was
non-mutagenic in both in vivo and in vitro assays.
Specific information on the studies received and the nature of the
adverse effects caused by dinotefuran as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies can be found at https://www.regulations.gov on pages 39-44 of the document titled ``Revised:
Dinotefuran: Human Health Risk Assessment for Proposed Section 3 Uses
on Tuberous and Corm Vegetables Subgroup 1C, Onion Subgroup 3-07A,
Onion Subgroup 3-07B, Small Fruit Subgroup 13-07F, Berry Subgroup 13-
07H, Peach, and Watercress, And a Tolerance on Imported Tea'' in docket
ID number EPA-HQ-OPP-2011-0433.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles
[[Page 56135]]
EPA uses in risk characterization and a complete description of the
risk assessment process, see https://www.epa.gov/pesticides/factsheets/riskassess.htm.
A summary of the toxicological endpoints for dinotefuran used for
human risk assessment is shown in the Table of this unit. EPA notes
that in the last final rule for dinotefuran, published in the Federal
Register of December 18, 2009 (74 FR 67098) (FRL-8803-1), the points of
departure for many exposure scenarios differ than what is reported in
this document. Since the last risk assessment, the Agency has re-
evaluated the dinotefuran toxicological database and updated the hazard
characterization and dose response assessment. This toxicology database
reevaluation has resulted in changes to the toxicity endpoints, points
of departure, and safety factors for several routes of exposure from
those presented in previous EPA risk assessments for dinotefuran. For a
more detailed discussion of the endpoint selection and reasons for the
changes, refer to Appendix A.3 on pages 44-47 in the document titled
``Dinotefuran: Human Health Risk Assessment for Proposed Section 3 Uses
on Tuberous and Corm Vegetables Subgroup 1C, Onion Subgroup 3-07A,
Onion Subgroup 3-07B, Small Fruit Subgroup 13-07F, Berry Subgroup 13-
07H, Peach, and Watercress, And a Tolerance on Imported Tea'' in docket
ID number EPA-HQ-OPP-2011-0433.
Table--Summary of Toxicological Doses and Endpoints for Dinotefuran for Use in Human Health Risk Assessment
----------------------------------------------------------------------------------------------------------------
Point of departure
Exposure/scenario and uncertainty/ RfD, PAD, LOC for Study and toxicological effects
safety factors risk assessment
----------------------------------------------------------------------------------------------------------------
Acute dietary (General population NOAEL = 125 mg/kg/ Acute RfD = 1.25 mg/ Developmental Toxicity Study in
including infants and children). day. kg/day. Rabbits
UFA = 10X........... aPAD = 1.25 mg/kg/ LOAEL = 300 mg/kg/day based on
UFH = 10X........... day. clinical signs in does (prone
FQPA SF = 1X........ position, panting, tremor and
erythema) seen following the
first dose on Gestation Day 6.
Chronic dietary (All populations) NOAEL= 99.7 mg/kg/ Chronic RfD = 1.0 Chronic Toxicity/Carcinogenicity
day. mg/kg/day. Study in Rats LOAEL = 991 mg/kg/
UFA = 10X........... cPAD = 1.0 mg/kg/ day based on decreased body
UFH = 10X........... day. weight gain and nephrotoxicity.
FQPA SF = 1X........
Incidental Oral Short-Term (1-30 NOAEL= 99.7 mg/kg/ LOC for MOE = 100.. Chronic Toxicity/Carcinogenicity
days). day. Study in Rats LOAEL = 991 mg/kg/
UFA = 10X........... day based on decreased body
UFH = 10X........... weight gain and nephrotoxicity.
FQPA SF = 1X........
----------------------------------------------------------------------------------------------------------------
FQPA SF = Food Quality Protection Act Safety Factor. LOAEL = lowest-observed-adverse-effect-level. LOC = level
of concern. mg/kg/day = milligram/kilogram/day. MOE = margin of exposure. NOAEL = no-observed-adverse-effect-
level. PAD = population adjusted dose (a = acute, c = chronic). RfD = reference dose. UF = uncertainty factor.
UFA = extrapolation from animal to human (interspecies). UFH = potential variation in sensitivity among
members of the human population (intraspecies).
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to dinotefuran, EPA considered exposure under the petitioned-
for tolerances as well as all existing dinotefuran tolerances in 40 CFR
180.603. EPA assessed dietary exposures from dinotefuran in food as
follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure.
Such effects were identified for dinotefuran. In estimating acute
dietary exposure, EPA used food consumption information from the United
States Department of Agriculture (USDA) 1994-1996 and 1998 Nationwide
Continuing Surveys of Food Intake by Individuals (CSFII). As to residue
levels in food, EPA assumed 100 percent crop treated (PCT) and
tolerance-level residues for all current and proposed crops.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the food consumption data from the USDA 1994-1996
and 1998 CSFII. As to residue levels in food, EPA assumed 100 PCT and
tolerance-level residues for all current and proposed crops.
iii. Cancer. Based on the data summarized in Unit III.A., EPA has
concluded that dinotefuran does not pose a cancer risk to humans.
Therefore, a dietary exposure assessment for the purpose of assessing
cancer risk is unnecessary.
iv. Anticipated residue and PCT information. EPA did not use
anticipated residue or PCT information in the dietary assessment for
dinotefuran. Tolerance level residues and 100 PCT were assumed for all
food commodities.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for dinotefuran in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of dinotefuran. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www.epa.gov/oppefed1/models/water/index.htm.
Based on the First Index Reservoir Screening Tool (FIRST), and
Screening Concentration in Ground Water (SCI-GROW) models, the
estimated drinking water concentrations (EDWCs) of dinotefuran for
acute exposures are estimated to be 91.31 parts per billion (ppb) for
surface water and 3.5 ppb for ground water and for chronic exposures
for non-cancer assessments are estimated to be 25.16 ppb for surface
water and 3.5 ppb for ground water.
Modeled estimates of drinking water concentrations were directly
entered into the dietary exposure model. For acute dietary risk
assessment, the water concentration value of 91.31 ppb was used to
assess the contribution to drinking water. For chronic dietary risk
[[Page 56136]]
assessment, the water concentration of value 25.16 ppb was used to
assess the contribution to drinking water.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets).
Dinotefuran is currently registered for the following uses that
could result in residential exposures: Turf, ornamentals, vegetable
gardens, pets, indoor aerosol sprays, and crack and crevice sprays. EPA
assessed residential exposure using the following assumptions:
Residential handler exposures were not assessed because no dermal or
inhalation hazards were identified. For this same reason, post-
application residential dermal and inhalation exposure scenarios were
not assessed. The Agency only considered post-application scenarios in
which incidental oral exposures to children are expected. The oral
exposures assessed included incidental oral exposures from turf, ant
bait, ready to use garden trigger sprayers, dog and cat spot on
treatment, indoor broadcast, and indoor crack and crevice uses. Of all
these scenarios, treated turf was determined to result in the highest
levels of exposure.
In assessing risks from residential exposures, EPA combines
different residential sources of exposure that could reasonably be
expected to occur on the same day. While it is possible for children to
be exposed to indoor broadcast sprays on hard surfaces/carpets and to
spot-on treatment to cats or dogs on the same day, these exposures have
not been combined in this assessment because incidental oral hand-to-
mouth exposure from treated turf is higher and still results in an MOE
that does not exceed the Agency's LOC.
Further information regarding EPA standard assumptions and generic
inputs for residential exposures may be found at https://www.epa.gov/pesticides/trac/science/trac6a05.pdf.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found dinotefuran to share a common mechanism of
toxicity with any other substances, and dinotefuran does not appear to
produce a toxic metabolite produced by other substances. For the
purposes of this tolerance action, therefore, EPA has assumed that
dinotefuran does not have a common mechanism of toxicity with other
substances. For information regarding EPA's efforts to determine which
chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's Web site at https://www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA Safety
Factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. In the pre-natal studies, no
maternal or developmental toxicity was seen at the limit dose in rats.
In rabbits, maternal toxicity manifested as clinical signs of
neurotoxicity but no developmental toxicity was seen. In the
reproduction study, parental, offspring, and reproductive toxicity was
seen at the limit dose. Parental toxicity included decreased body
weight gain, transient decrease in food consumption, and decreased
thyroid weights. Offspring toxicity was characterized as decreased
forelimb grip strength or hindlimb grip strength in the F1 pups. There
was no adverse effect on reproductive performance at any dose. In the
developmental neurotoxicity study, no maternal or offspring toxicity
was seen at any dose including the limit dose.
3. Conclusion. EPA has determined that reliable data show the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1X. That decision is based on the following
findings:
i. The toxicity database for dinotefuran is complete.
ii. The neurotoxic potential of dinotefuran has been adequately
considered. Dinotefuran is a neonicotinoid and has a neurotoxic mode of
pesticidal action. Consistent with the mode of action, changes in motor
activity were seen in repeat-dose studies, including the subchronic
neurotoxicity study. Additionally, decreased grip strength and brain
weight was observed in the offspring of a multi-generation reproduction
study albeit at doses close to the limit dose. For these reasons, a
developmental neurotoxicity study was required. Upon review of the
developmental neurotoxicity study, it was concluded that there is no
evidence of a unique sensitivity to the developing nervous system since
no effects on neurobehavioral parameters were seen in the offspring at
doses that approached or exceeded the limit dose.
iii. There is no evidence that dinotefuran results in increased
susceptibility in in utero rats or rabbits in the prenatal
developmental studies or in young rats in the 2-generation reproduction
study.
iv. There are no residual uncertainties identified in the exposure
databases. The dietary food exposure assessments were performed based
on 100 PCT and tolerance-level residues. EPA made conservative
(protective) assumptions in the ground and surface water modeling used
to assess exposure to dinotefuran in drinking water. EPA used similarly
conservative assumptions to assess postapplication exposure of children
for incidental oral exposures. These assessments will not underestimate
the exposure and risks posed by dinotefuran.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA
calculates the lifetime probability of acquiring cancer given the
estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the appropriate PODs to ensure that an
adequate MOE exists.
1. Acute risk. Using the exposure assumptions discussed in this
unit for acute exposure, the acute dietary exposure from food and water
to dinotefuran will occupy 5.8% of the aPAD for children 1-2 years old,
the population group receiving the greatest exposure.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
dinotefuran from food and water will utilize 2.6% of the cPAD for
children 1-2 years old, the population group receiving the greatest
exposure. Based on the explanation in
[[Page 56137]]
Unit III.C.3., regarding residential use patterns, chronic residential
exposure to residues of dinotefuran is not expected.
3. Short-term risk. Short-term aggregate exposure takes into
account short-term residential exposure plus chronic exposure to food
and water (considered to be a background exposure level).
Dinotefuran is currently registered for uses that could result in
short-term residential exposure, and the Agency has determined that it
is appropriate to aggregate chronic exposure through food and water
with short-term residential exposures to dinotefuran.
Using the exposure assumptions described in this unit for short-
term exposures, EPA has concluded the combined short-term food, water,
and residential exposures result in an aggregate MOE of 3,000 for
children 1-2 years old from hand to mouth exposure from treated turf,
the scenario with the highest exposure. Because EPA's level of concern
for dinotefuran is a MOE of 100 or below, this MOE is not of concern.
4. Intermediate-term risk. Intermediate-term aggregate exposure
takes into account intermediate-term residential exposure plus chronic
exposure to food and water (considered to be a background exposure
level).
Intermediate-term exposure is not expected for the adult
residential exposure pathway. Therefore, the intermediate-term
aggregate risk would be equivalent to the chronic dietary exposure
estimate. For children, intermediate-term incidental oral exposures
could potentially occur from indoor uses. However, while it is possible
for children to be exposed for longer durations, the magnitude of
residues is expected to be lower due to dissipation or other
activities. Since incidental oral short- and intermediate-term toxicity
endpoints and points of departure are the same, the short-term
aggregate risk estimate, which includes the highest residential
exposure estimate (from turf), is protective of any intermediate-term
exposures.
5. Aggregate cancer risk for U.S. population. Based on the lack of
evidence of carcinogenicity in two adequate rodent carcinogenicity
studies, dinotefuran is not expected to pose a cancer risk to humans.
6. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population or to infants and children from aggregate
exposure to dinotefuran residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology (a high performance liquid
chromatography/tandem mass spectrometry (HPLC/MS/MS) method for the
determination of residues of dinotefuran, and the metabolites DN, and
UF; an HPLC/ultraviolet (UV) detection method for the determination of
residues of dinotefuran; and HPLC/MS and HPLC/MS/MS methods for the
determination of DN and UF) is available to enforce the tolerance
expression.
The method may be requested from: Chief, Analytical Chemistry
Branch, Environmental Science Center, 701 Mapes Rd., Ft. Meade, MD
20755-5350; telephone number: (410) 305-2905; email address:
residuemethods@epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level.
The Codex has not established a MRL for dinotefuran for any of the
commodities in this Notice.
C. Revisions to Petitioned-For Tolerances
Use of the Organization of Economic and Cooperation and Development
tolerance calculation procedures indicates that the tolerances for
residues in/on the onion subgroup 3-07A, onion subgroup 3-07B, peach,
tea, and watercress should be established at 0.15 ppm, 5.0 ppm, 1.0
ppm, 50 ppm, and 8.0 ppm, respectively, instead of those values
proposed.
V. Conclusion
Therefore, tolerances are established for residues of dinotefuran,
(RS)-1-methyl-2-nitro-3-((tetrahydro-3-furyl)methyl)guanidine,
including its metabolites and degradates, in or on berry, low growing,
except strawberry, subgroup 13-07H at 0.2 ppm; watercress at 8.0 ppm;
onion, green, subgroup 3-07B at 5.0 ppm; onion, bulb, subgroup 3-07A at
0.15 ppm; peach at 1.0 ppm; vegetable, tuberous and corm, subgroup 1C
at 0.05 ppm; fruit, small, vine climbing, except fuzzy kiwifruit,
subgroup 13-07F at 0.9 ppm; and tea, dried at 50 ppm.
Also, the following existing tolerances are removed as unnecessary:
Grape and potato. These commodities are covered by the new crop group
tolerances for fruit, small, vine climbing, except fuzzy kiwifruit,
subgroup 13-07F, and vegetable, tuberous and corm, subgroup 1C.
VI. Statutory and Executive Order Reviews
This final rule establishes tolerances under FFDCA section 408(d)
in response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this final rule has
been exempted from review under Executive Order 12866, this final rule
is not subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997). This final rule does not contain
any information collections subject to OMB approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any
special considerations under Executive Order 12898, entitled ``Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerance in this
final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This final rule directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
[[Page 56138]]
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this final rule. In addition,
this final rule does not impose any enforceable duty or contain any
unfunded mandate as described under Title II of the Unfunded Mandates
Reform Act of 1995 (UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act of 1995 (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: August 28, 2012.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Section Sec. 180.603 is amended by removing the entries for
``Grape'' and ``Potato'' and alphabetically adding the following
entries and a footnote to the table in paragraph (a)(1) to read as
follows:
Sec. 180.603 Dinotefuran; tolerances for residues.
(a) * * *
(1) * * *
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Berry, low growing, except strawberry, subgroup 13-07H.... 0.2
* * * * * * *
Fruit, small vine climbing, except fuzzy kiwifruit, 0.9
subgroup 13-07F..........................................
* * * * * * *
Onion, bulb, subgroup 3-07A............................... 0.15
Onion, green, subgroup 3-07B.............................. 5.0
Peach..................................................... 1.0
* * * * * * *
Tea, dried\1\............................................. 50
* * * * * * *
Vegetable, tuberous and corm, subgroup 1C................. 0.05
Watercress................................................ 8.0
------------------------------------------------------------------------
\1\ There are no U.S. registrations for tea.
* * * * *
[FR Doc. 2012-22205 Filed 9-11-12; 8:45 am]
BILLING CODE 6560-50-P